Published in J Bone Miner Res on February 01, 2001
Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest (2005) 5.19
Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest (2006) 3.45
A novel T cell cytokine, secreted osteoclastogenic factor of activated T cells, induces osteoclast formation in a RANKL-independent manner. Arthritis Rheum (2009) 1.70
IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells. Proc Natl Acad Sci U S A (2002) 1.65
Positive regulators of osteoclastogenesis and bone resorption in rheumatoid arthritis. Arthritis Res Ther (2011) 1.51
Estrogen prevents bone loss through transforming growth factor beta signaling in T cells. Proc Natl Acad Sci U S A (2004) 1.32
Characterization of osteoclasts derived from CD14+ monocytes isolated from peripheral blood. J Bone Miner Metab (2007) 1.26
HIV: inflammation and bone. Curr HIV/AIDS Rep (2012) 1.23
The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis. Scientifica (Cairo) (2013) 1.20
Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: a new candidate in the pathogenesis of osteoporosis. PLoS One (2012) 1.19
The immune system and bone. Arch Biochem Biophys (2010) 1.19
Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha. Ann Rheum Dis (2004) 1.14
Exposure to receptor-activator of NFkappaB ligand renders pre-osteoclasts resistant to IFN-gamma by inducing terminal differentiation. Arthritis Res Ther (2002) 1.06
Inflammatory markers and the risk of hip fracture: the Women's Health Initiative. J Bone Miner Res (2012) 1.05
CD4+CD45RBHi T cell transfer induced colitis in mice is accompanied by osteopenia which is treatable with recombinant human osteoprotegerin. Gut (2005) 1.00
Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir. J Infect Dis (2015) 0.99
Relationships between inflammation, immune activation, and bone health among HIV-infected adults on stable antiretroviral therapy. J Acquir Immune Defic Syndr (2014) 0.99
IL-7 up-regulates TNF-alpha-dependent osteoclastogenesis in patients affected by solid tumor. PLoS One (2006) 0.95
Inflammatory markers and risk of hip fracture in older white women: the study of osteoporotic fractures. J Bone Miner Res (2014) 0.95
Osteoclasts-Key Players in Skeletal Health and Disease. Microbiol Spectr (2016) 0.88
Bone loss in surgically ovariectomized premenopausal women is associated with T lymphocyte activation and thymic hypertrophy. J Investig Med (2013) 0.87
CTLA-4Ig-induced T cell anergy promotes Wnt-10b production and bone formation in a mouse model. Arthritis Rheumatol (2014) 0.86
Transplantation of SHED prevents bone loss in the early phase of ovariectomy-induced osteoporosis. J Dent Res (2014) 0.85
T-cells and B-cells in osteoporosis. Curr Opin Endocrinol Diabetes Obes (2014) 0.84
Interactions between the immune system and bone. World J Orthop (2011) 0.83
VEGF165 promotes the osteolytic bone destruction of ewing's sarcoma tumors by upregulating RANKL. Oncol Res (2009) 0.83
Osteoprotegerin. Ann Rheum Dis (2001) 0.81
Modulation of osteoclastogenesis induced by nucleoside reverse transcriptase inhibitors. AIDS Res Hum Retroviruses (2006) 0.80
Impact of the Oral Commensal Flora on Alveolar Bone Homeostasis. J Dent Res (2014) 0.79
Inflammatory Markers and the Risk of Hip and Vertebral Fractures in Men: the Osteoporotic Fractures in Men (MrOS). J Bone Miner Res (2016) 0.78
Do γδ T cells predict osteonecrosis of the jaw? J Bone Miner Res (2013) 0.77
Effects of the anti-inflammatory drug salsalate on bone turnover in type 2 diabetes mellitus. Endocrine (2015) 0.77
Dendritic Cells Cause Bone Lesions in a New Mouse Model of Histiocytosis. PLoS One (2015) 0.75
Expression of SOFAT by T- and B-lineage cells may contribute to bone loss. Mol Med Rep (2016) 0.75
Activation status of γδ T cells dictates their effect on osteoclast generation and bone resorption. Bone Rep (2015) 0.75
Does systemic inflammation and immune activation contribute to fracture risk in HIV? Curr Opin HIV AIDS (2016) 0.75
Adverse bone health among children and adolescents growing up with HIV. J Virus Erad (2015) 0.75
Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest (2000) 3.15
Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology (1994) 2.62
Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci U S A (2001) 2.56
Occupational carpal tunnel syndrome in Washington State, 1984-1988. Am J Public Health (1991) 2.12
Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J Clin Invest (1994) 2.00
STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation. Immunity (2001) 1.81
Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology (1995) 1.75
Interleukin-7 stimulates osteoclast formation by up-regulating the T-cell production of soluble osteoclastogenic cytokines. Blood (2000) 1.74
Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis. Proc Natl Acad Sci U S A (1987) 1.70
Outcome of lumbar fusion in Washington State workers' compensation. Spine (Phila Pa 1976) (1994) 1.69
Drug monitoring in nonconventional biological fluids and matrices. Clin Pharmacokinet (1996) 1.57
Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production. J Biol Chem (1996) 1.55
Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci U S A (1989) 1.54
The in-vitro effects of nicotine and cotinine on sperm motility. Hum Reprod (1997) 1.53
Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD. J Clin Invest (1999) 1.50
Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats. J Clin Invest (1994) 1.50
Determination of maternal-fetal biomarkers of prenatal exposure to ethanol: a review. J Pharm Biomed Anal (2012) 1.47
Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation. J Biol Chem (2000) 1.47
Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression. Mol Biol Cell (2003) 1.46
The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice. J Bone Miner Res (1997) 1.42
Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1. J Clin Invest (1998) 1.38
Cytokines, estrogen, and postmenopausal osteoporosis--the second decade. Endocrinology (1998) 1.33
M-CSF neutralization and egr-1 deficiency prevent ovariectomy-induced bone loss. J Clin Invest (2000) 1.33
Effects of new smoking regulations in Italy. Ann Oncol (2005) 1.32
Cord serum cotinine as a biomarker of fetal exposure to cigarette smoke at the end of pregnancy. Environ Health Perspect (2000) 1.20
Expression of VEGF and its receptors by myeloma cells. Leukemia (2003) 1.18
Human pain responsivity in a tonic pain model: psychological determinants. Pain (1989) 1.17
Household and community determinants of exposure to involuntary smoking: a study of urinary cotinine in children and adolescents. Am J Epidemiol (1995) 1.16
Osteoporosis: diagnosis with lateral and posteroanterior dual x-ray absorptiometry compared with quantitative CT. Radiology (1994) 1.13
Topographic brain measures of human pain and pain responsivity. Pain (1989) 1.11
Liver collagen synthesis in murine schistosomiasis. J Clin Invest (1977) 1.11
Immunological changes among farmers exposed to phenoxy herbicides: preliminary observations. Occup Environ Med (1996) 1.05
Serum cotinine as a marker of environmental tobacco smoke exposure in epidemiological studies: the experience of the MATISS project. Eur J Epidemiol (2003) 1.05
Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria. J Clin Endocrinol Metab (1990) 1.05
The effect of zinc and vitamin A supplementation on immune response in an older population. J Am Geriatr Soc (1998) 1.04
Lung function in children and adolescents with occasional exposure to environmental tobacco smoke. Am J Respir Crit Care Med (1996) 1.00
Hair analysis for nicotine and cotinine: evaluation of extraction procedures, hair treatments, and development of reference material. Forensic Sci Int (1997) 0.99
B lymphocytes inhibit human osteoclastogenesis by secretion of TGFbeta. J Cell Biochem (2000) 0.98
Morphine and methadone impact on human phagocytic physiology. Int J Immunopharmacol (1985) 0.98
MRK003, a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphoma. Leukemia (2011) 0.98
Dual-energy x-ray absorptiometry of the rat: accuracy, precision, and measurement of bone loss. J Bone Miner Res (1993) 0.97
Rapid screening method for determination of Ecstasy and amphetamines in urine samples using gas chromatography-chemical ionisation mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.97
Bone matrix constituents stimulate interleukin-1 release from human blood mononuclear cells. J Clin Invest (1991) 0.97
Tobacco dependence in the general population in Italy. Ann Oncol (2005) 0.96
Bone re/modeling is more dynamic in the endothelial nitric oxide synthase(-/-) mouse. Endocrinology (2006) 0.96
Human blood-mobilized hematopoietic precursors differentiate into osteoclasts in the absence of stromal cells. Proc Natl Acad Sci U S A (1996) 0.96
Production of interleukin-6 in human osteoblasts and human bone marrow stromal cells: evidence that induction by interleukin-1 and tumor necrosis factor-alpha is not regulated by ovarian steroids. Endocrinology (1995) 0.96
Age-related cortical bone loss at the metacarpal. Calcif Tissue Int (1997) 0.95
Presence of epidermal growth factor receptors and influence of epidermal growth factor on proliferation and aging in cultured smooth muscle cells. J Cell Physiol (1979) 0.94
Regulation of 25 hydroxyvitamin D3 1-hydroxylase in serum-free monolayer culture of mouse kidney. Endocrinology (1982) 0.94
Bone and cytokines: beyond IL-1, IL-6 and TNF-alpha. Calcif Tissue Int (1999) 0.93
Single and dual energy tomographic analysis of spinal trabecular bone: a comparative study in normal and osteoporotic women. J Clin Endocrinol Metab (1987) 0.92
Overexpression of cyclin D1 in the Dami megakaryocytic cell line causes growth arrest. Blood (1995) 0.92
Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study. J Psychopharmacol (2008) 0.92
Is there a causal role for IL-1 in postmenopausal bone loss? Calcif Tissue Int (1992) 0.92
Pregnancy-associated osteoporosis: report of two cases with long-term bone density follow-up. Br J Rheumatol (1994) 0.91
Questionnaire data as predictors of urinary cotinine levels among nonsmoking adolescents. Arch Environ Health (1993) 0.91
Systemic mastocytosis presenting as osteoporosis: a clinical and histomorphometric study. J Clin Endocrinol Metab (1991) 0.90
Aging and cytokine production. Calcif Tissue Int (1999) 0.90
Interference of nicotine metabolites in cotinine determination by RIA. Clin Chem (1997) 0.90
Laser-Induced, Polarization Dependent Shape Transformation of Au/Ag Nanoparticles in Glass. Nanoscale Res Lett (2009) 0.90
Cigarette smoking and hypertension influence nitric oxide release and plasma levels of adhesion molecules. Clin Chem Lab Med (2001) 0.90
Diagnosis and management of osteoporosis: guidelines for the utilization of bone densitometry. Calcif Tissue Int (1997) 0.89
Disease-relevant proteostasis regulation of cystic fibrosis transmembrane conductance regulator. Cell Death Differ (2013) 0.89
Simultaneous determination of cotinine and trans-3'-hydroxycotinine in human serum by high-performance liquid chromatography. J Chromatogr (1992) 0.88
Macrophage-derived growth factor for osteoblast-like cells and chondrocytes. Proc Natl Acad Sci U S A (1984) 0.88
J774A.1 macrophage cell line produces PDGF-like and non-PDGF-like growth factors for bone cells. J Bone Miner Res (1987) 0.88
Drugs in nails: physiology, pharmacokinetics and forensic toxicology. Clin Pharmacokinet (2000) 0.88
Monocytic secretion of interleukin-1 receptor antagonist in normal and osteoporotic women: effects of menopause and estrogen/progesterone therapy. J Clin Endocrinol Metab (1993) 0.88
Idiopathic hypercalciuria and osteoporosis--distinct clinical manifestations of increased cytokine-induced bone resorption? J Clin Endocrinol Metab (1997) 0.88
Determination of opiates and cocaine in hair as trimethylsilyl derivatives using gas chromatography-tandem mass spectrometry. J Anal Toxicol (1999) 0.87
Fat body mass and pharmacokinetics of oral 6-mercaptopurine in children with acute lymphoblastic leukemia. Ther Drug Monit (1991) 0.87
Drugs in semen. Clin Pharmacokinet (1994) 0.87
X-linked hypophosphatemic rickets and the murine Hyp homologue. Am J Physiol (1995) 0.87
Effect of physical fitness and endurance exercise on indirect biomarkers of recombinant erythropoietin misuse. Int J Sports Med (2006) 0.87
Determination of nicotine and four metabolites in the serum of smokers by high-performance liquid chromatography with ultraviolet detection. J Chromatogr (1993) 0.86
On-site screening and GC-MS analysis of cocaine and heroin metabolites in body-packers urine. J Pharm Biomed Anal (2007) 0.86
Prenatal exposure to arecoline (areca nut alkaloid) and birth outcomes. Arch Dis Child Fetal Neonatal Ed (2005) 0.86
Evidence for interleukin-1 beta production by cultured normal human osteoblast-like cells. J Bone Miner Res (1991) 0.86
The analysis of nicotine in infants' hair for measuring exposure to environmental tobacco smoke. Forensic Sci Int (1997) 0.86
Solid-phase extraction of nicotine and its metabolites for high-performance liquid chromatographic determination in urine. J Chromatogr B Biomed Appl (1995) 0.86
IL-1-induced murine osteoblast IL-6 production is mediated by the type 1 IL-1 receptor and is increased by 1,25 dihydroxyvitamin D3. J Clin Invest (1993) 0.85
Personality, endocrine and immune changes after eight months in healthy individuals under normal daily stress. Psychother Psychosom (1994) 0.85
Role of TNF-alpha producing T-cells in bone loss induced by estrogen deficiency. Minerva Med (2004) 0.85
Increased production of inflammatory cytokines in patients with silent myocardial ischemia. J Am Coll Cardiol (2001) 0.85
Purification and characterization of human myometrial smooth muscle collagenase. Arch Biochem Biophys (1988) 0.85
Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants. Biol Blood Marrow Transplant (2004) 0.85
ErbB receptor activation, cell morphology changes, and apoptosis induced by anti-Her2 monoclonal antibodies. Biochem Biophys Res Commun (1996) 0.84
Immature germ cell separation using a modified discontinuous Percoll gradient technique in human semen. Hum Reprod (1999) 0.84